Skip to content

LBC Learning Collaborative Participant Website

Welcome to the RAISE Learning Collaborative on Low-Barrier Care for HIV Treatment!

The webpage is intended for members of the RAISE Learning Collaborative (launched 2026) on low-barrier care for HIV treatment. Below, please find our program schedule, meeting notes, and additional resources. Please email uvhivishub@uw.edu with any questions.

Learning Collaborative Objectives
By the end of this collaborative, participating jurisdictions will have increased their capacity to:

  • Design a low-barrier care strategy for HIV treatment
  • Implement low-barrier care for HIV treatment
  • Monitor the implementation process of a low-barrier care strategy for HIV treatment
  • Evaluate the impact of a low-barrier care strategy for HIV treatment

Meeting Materials

Meeting materials and resources will be posted after each group meeting. Note, this page is password protected.

LBC Resources

Below are some resources about low barrier care for HIV treatment. We will add to this list as additional resources are published and if any other resources are discussed during meetings. If you come across resources that you think others might find helpful, email uwhivishub@uw.edu so we can add them to this list!

Community-Embedded Low-Barrier Care: A Model for Engaging People With Complex Needs in HIV Treatment and Prevention (Corcorran et al, 2025)

POP-UP Mobile: A Mixed Methods Study of Mobile Outreach for People with HIV with Housing Instability Who Are Out of Care from a Low-Barrier Clinical Program in San Francisco (Conte et al, 2025)

Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia (Hickey et al, 2025)

Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed (Hickey et al, 2025)

Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness (Mehtani et al, 2024)

Implementation of Low-Barrier Human Immunodeficiency Virus Care: Lessons Learned From the Max Clinic in Seattle (Dombrowski et al, 2023)

Adaptation of the collaborative care model to integrate behavioral health care into a low-barrier HIV clinic (Dombrowski et al, 2023)

HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing Homelessness (Hickey et al, 2024)

The Impact of a Walk-in Human Immunodeficiency Virus Care Model for People Who Are Incompletely Engaged in Care: The Moderate Needs (MOD) Clinic (Kumbhakar et al, 2022)

“It’s Me as a Person, Not Me the Disease”: Patient Perceptions of an HIV Care Model Designed to Engage Persons with Complex Needs (Beima-Sofie et al, 2020)

HIV Care for Patients With Complex Needs: A Controlled Evaluation of a Walk-In, Incentivized Care Model (Dombrowski et al, 2019)

The Max Clinic: Medical Care Designed to Engage the Hardest-to-Reach Persons Living with HIV in Seattle and King County, Washington (Dombrowski et al, 2018)

National HIV Curriculum: Free online AETC curriculum covering screening and diagnosis, basic HIV primary care, antiretroviral therapy, co-occurring conditions, HIV prevention and key populations. Continuing Education (CNE/CME) available.

The Collaborative to Enhance Access for Suppression to End HIV (CEASE-HIV) aims to implement and evaluate LBC in the Chicago Eligible Metropolitan Area. Resources developed through CEASE-HIV and provided on their website include example models of LBC, standard operating procedure templates, and tools for tracking implementation. 

Data 2 Care Resources

Below are some resources about data-to-care strategies. These materials were discussed in our March 2026 group meeting.

D2C Avoundijan T et al. Sex Transm Dis 2020

D2C Roberts KT et al. AIDS and Behavior 2025

D2C & Jails Eastment et al. AJPH Research 2017

D2C & Jails Erly et et al. BMC Public Health 2025

D2C & STI Surveillance Norkin S et al. Sex Transm Dis 2021

ED D2C Sharp J et al. Open Forum Infect Dis 2019

Pharma D2C Dombrowski JC et al. Sx Transm Dis 2025